Speeding up the
delivery of
Alzheimer’s &
Parkinson’s treatments.
The Global Alzheimer’s Platform Foundation® (GAP) is dedicated to accelerating the delivery of treatments, therapies, and cures for people living with neurodegenerative diseases, like dementia, Alzheimer’s, Parkinson’s and Multiple Sclerosis. GAP works to lower costs and improve the efficacy of clinical trials and is committed to ensuring that no one is left behind.
Bio-Hermes biospecimens are now available for sale.
Plasma, serum, and PBMC samples from the largest blood-based biomarker study in Alzheimer’s research — ready to accelerate your discovery work.
A generation is waiting for more options and more time.
Global network of research sites working in concert.
GAP-Net connects leading private and academic research sites across North America, the United Kingdom, and Europe — every dot below is an active site that is or has run neurodegenerative trials with us.
Through our Trial Execution Services (TES) teams, GAP Participant Services (GPS Liaisons) and our Inclusive Research Initiative (Community Connectors), research opportunities extend beyond the research site, into communities and improving access to cutting edge science and technology.
Learn more about our Trial Execution ServicesBuilding a foundation for faster trials.
A track record of supporting industry-funded studies and initiating GAP-sponsored research that the field needs.